[Dec 2020] IMMAGINA BioTechnology presents, together with its partners at Genexa, TB-seq, the Institute for Biophysics at CNR Trento and the Edinburgh Medical School, Biomedical Sciences a preprint publication featuring the first commercially available Phospho RNA sequencing kit called circAID-pseq (CIRCular Amplification and IDentification of short 3′ Phosphate RNA SEQuences). Press release / Go to […]
Immagina Biotech is very pleased to announce the appointment of Tri-I Biotech Inc as its official distributor in Taiwan to further expand and grow its business operations in Asia.
RiboLace to study Spinal Muscular Atrophy.
SMN-primed ribosomes modulate the translation of transcripts related to Spinal Muscular Atrophy
We are excited to share the winners of the
Immagina Ribo-Omics Grant Challenge 2020.
IMMAGINA BIOTECHNOLOGY and TomaLab are excited to host a series of free live scientific webinars. During the webinars, prestigious speakers will present their recent researches carried out by the use of IMMAGINA BIOTECH products for the study of translational control of gene expression and diseases.
We are working together to develop a powerful data analysis tool for the only product available for 3’ phospho-RNA sequencing with ONT platform, CircAID-p-seq! Genexa is a service provider for bioinformatic analyses based in Zurich, Switzerland. Genexa’s services are centered around the analysis of third- and next-generation genomics data and the development of novel data […]
We are glad to announce that we were awarded the EIT headstart grant to further investigate circAID-p-seq applications in the pharma sector
One-shot analysis of translated mammalian lncRNAs with AHARIBO
In February 2020 IMMAGINA raised 1 M Euro from existing investors and new, undisclosed EU-based investors. The Company has raised about 2 M Euro to date
Our preprint work describing new probes to sense the activity of protein synthesis and to capture associated RNA is now available on bioRxiv